2026 Q3 Portfolio Activity
In 2026 Q3, BRAIDWELL LP maintained a portfolio of 102 distinct positions. The most significant new addition was NUVECTIS PHARMA INC, now representing 1.38% of the total fund value. They heavily accumulated shares in ALPHATEC HLDGS INC, increasing the position by 27548.4%. Conversely, BRAIDWELL LP completely exited their position in ALPHATEC HLDGS INC.
Position History
hover any row below to update
Loading…
Total Positions
102
Quarter
2026 Q3
Top Holding
KOD (4.3%)
Top 10 Concentration
30.7%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 102
BRAIDWELL LP Full Holdings List — 2026 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
KOD
KODIAK SCIENCES...
|
Healthcare | 4.27% | 2.58% |
#1
7
Prev: #8
|
3.7 |
—
|
-701,575 | -39.3% |
P
S
|
1,085,743 | $102,928,436 | 2022 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CAI
CARIS LIFE SCIE...
|
Healthcare | 3.49% | 5.44% |
#2
1
Prev: #1
|
2.9 |
—
|
-5,509,344 | -66.7% |
P
S
|
2,746,688 | $84,131,053 | 2025 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
EWTX
EDGEWISE THERAP...
|
Healthcare | 3.49% | 3.00% |
#3
1
Prev: #4
|
2.9 |
—
|
72,126 | 3.6% |
P
S
|
2,069,091 | $84,005,095 | 2024 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ATEC
ALPHATEC HLDGS ...
|
Healthcare | 3.10% | 2.09% |
#4
10
Prev: #14
|
3.7 |
—
|
697,400 | 10.7% |
P
S
|
7,228,839 | $74,601,618 | 2023 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
IRTC
IRHYTHM HOLDING...
|
Healthcare | 3.02% | 2.88% |
#5
1
Prev: #6
|
2.2 |
—
|
-13,700 | -2.1% |
P
S
|
640,562 | $72,806,277 | 2022 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
N/A
ALPHATEC HLDGS ...
|
|
Bond/Debt | 2.88% | 2.45% |
#6
4
Prev: #10
|
2.2 |
—
|
no change | no change |
P
S
|
69,121,000 | $69,329,620 | — | 13F Filing | 2026-09-30 | 2026-11-16 | ||
|
HNGE
HINGE HEALTH IN...
|
Healthcare | 2.64% | 4.08% |
#7
5
Prev: #2
|
1.1 |
—
|
-674,821 | -50.7% |
P
S
|
655,306 | $63,721,955 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SYRE
SPYRE THERAPEUT...
|
Healthcare | 2.64% | 2.89% |
#8
3
Prev: #5
|
1.6 |
—
|
-165,510 | -18.8% |
P
S
|
713,957 | $63,563,592 | 2023 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
XENE
XENON PHARMACEU...
|
Healthcare | 2.64% | 2.53% |
#9
Prev: #9
|
4.1 |
—
|
576,983 | 51.0% |
P
S
|
1,708,435 | $63,536,698 | 2022 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
NEO
NEOGENOMICS INC
|
Healthcare | 2.55% | 2.65% |
#10
3
Prev: #7
|
1.0 |
—
|
-1,569,700 | -31.9% |
P
S
|
3,348,502 | $61,478,497 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
GKOS
GLAUKOS CORP
|
Healthcare | 2.34% | 3.06% |
#11
8
Prev: #3
|
0.9 |
—
|
-248,054 | -41.9% |
P
S
|
343,873 | $56,460,508 | 2022 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
VERA
VERA THERAPEUTI...
|
Healthcare | 2.31% | 0.90% |
#12
33
Prev: #45
|
3.9 |
—
|
1,161,969 | 205.8% |
P
S
|
1,726,693 | $55,754,917 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TMDX
TRANSMEDICS GRO...
|
Healthcare | 2.27% | 1.50% |
#13
12
Prev: #25
|
2.9 |
—
|
44,463 | 7.3% |
P
S
|
654,178 | $54,591,154 | 2022 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ISRG
INTUITIVE SURGI...
|
Healthcare | 2.13% | 1.03% |
#14
25
Prev: #39
|
3.9 |
—
|
55,820 | 79.6% |
P
S
|
125,957 | $51,217,895 | 2022 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
AVAH
AVEANNA HEALTHC...
|
Healthcare | 1.99% | 0.97% |
#15
27
Prev: #42
|
3.3 |
—
|
805,000 | 26.3% |
P
S
|
3,870,106 | $48,028,015 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
NBIX
NEUROCRINE BIOS...
|
Healthcare | 1.98% | 2.10% |
#16
3
Prev: #13
|
1.3 |
—
|
400 | 0.1% |
P
S
|
336,571 | $47,739,231 | 2023 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 1.89% | 2.14% |
#17
5
Prev: #12
|
1.3 |
—
|
-76,164 | -12.8% |
P
S
|
518,398 | $45,644,944 | 2024 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
BTSG
BRIGHTSPRING HE...
|
Healthcare | 1.89% | 1.54% |
#18
6
Prev: #24
|
3.3 |
—
|
205,719 | 34.5% |
P
S
|
802,472 | $45,540,286 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
GENB
GENERATE BIOMED...
|
Healthcare | 1.85% | 2.05% |
#19
4
Prev: #15
|
1.2 |
—
|
-321,595 | -9.8% |
P
S
|
2,962,249 | $44,492,980 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MRVI
MARAVAI LIFESCI...
|
Healthcare | 1.75% | 2.01% |
#20
4
Prev: #16
|
0.7 |
—
|
-3,199,835 | -36.8% |
P
S
|
5,503,086 | $42,153,639 | 2023 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
KRYS
KRYSTAL BIOTECH...
|
Healthcare | 1.57% | 1.77% |
#21
4
Prev: #17
|
1.1 |
—
|
-14,898 | -11.6% |
P
S
|
114,077 | $37,937,447 | 2022 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ACHC
ACADIA HEALTHCA...
|
Healthcare | 1.54% | 1.25% |
#22
9
Prev: #31
|
2.6 |
—
|
211,216 | 18.5% |
P
S
|
1,352,693 | $37,199,058 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
N/A
DAMORA THERAPEU...
|
|
Unknown | 1.54% | — |
#23
Prev: #—
|
4.1 |
—
|
1,747,659 | — |
NEW
|
1,747,659 | $37,190,184 | — | 13F Filing | 2026-09-30 | 2026-11-16 | ||
|
ALMR
ALAMAR BIOSCIEN...
|
Healthcare | 1.53% | 1.09% |
#24
13
Prev: #37
|
1.6 |
—
|
no change | no change |
P
S
|
1,083,983 | $36,931,301 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
KYMR
KYMERA THERAPEU...
|
Healthcare | 1.39% | 1.60% |
#25
5
Prev: #20
|
0.6 |
—
|
-77,594 | -20.5% |
P
S
|
300,569 | $33,600,609 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
NVCT
NUVECTIS PHARMA...
|
Healthcare | 1.38% | — |
#26
Prev: #—
|
4.1 |
—
|
1,573,823 | — |
NEW
|
1,573,823 | $33,239,142 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CLYM
CLIMB BIO INC
|
Healthcare | 1.36% | 1.35% |
#27
Prev: #27
|
1.0 |
—
|
65,975 | 2.4% |
P
S
|
2,863,350 | $32,842,625 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
INSP
INSPIRE MED SYS...
|
Healthcare | 1.34% | 1.12% |
#28
7
Prev: #35
|
0.5 |
—
|
-213,100 | -31.5% |
P
S
|
464,470 | $32,215,639 | 2023 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
DHR
DANAHER CORP DE...
|
Healthcare | 1.30% | 1.06% |
#29
9
Prev: #38
|
1.0 |
—
|
-9,123 | -6.1% |
P
S
|
141,504 | $31,350,211 | 2023 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MAZE
MAZE THERAPEUTI...
|
Healthcare | 1.30% | 1.26% |
#30
1
Prev: #29
|
1.0 |
—
|
9,695 | 0.9% |
P
S
|
1,149,735 | $31,249,797 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
HUM
HUMANA INC
|
Healthcare | 1.29% | 1.68% |
#31
13
Prev: #18
|
0.5 |
—
|
-33,101 | -28.9% |
P
S
|
81,399 | $31,059,416 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
GLUE
MONTE ROSA THER...
|
Healthcare | 1.25% | 2.19% |
#32
21
Prev: #11
|
1.0 |
—
|
74,447 | 3.0% |
P
S
|
2,526,009 | $30,135,287 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TEVJF
TEVA PHARMACEUT...
|
Healthcare | 1.24% | — |
#33
Prev: #—
|
4.0 |
—
|
753,537 | — |
NEW
|
753,537 | $29,840,065 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TMO
THERMO FISHER S...
|
Healthcare | 1.17% | 1.66% |
#34
15
Prev: #19
|
0.5 |
—
|
-47,720 | -53.4% |
P
S
|
41,675 | $28,132,709 | 2023 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
IMCR
IMMUNOCORE HLDG...
|
Healthcare | 1.14% | 0.61% |
#35
21
Prev: #56
|
3.5 |
—
|
384,788 | 73.8% |
P
S
|
906,115 | $27,446,223 | 2023 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
NKTR
NEKTAR THERAPEU...
|
Healthcare | 1.11% | 1.22% |
#36
4
Prev: #32
|
0.9 |
—
|
-30,026 | -6.3% |
P
S
|
443,591 | $26,857,217 | 2022 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ORKA
ORUKA THERAPEUT...
|
Healthcare | 1.11% | 0.98% |
#37
3
Prev: #40
|
2.4 |
—
|
41,515 | 14.9% |
P
S
|
319,679 | $26,626,064 | 2024 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
BSX
BOSTON SCIENTIF...
|
Healthcare | 1.06% | 0.93% |
#38
6
Prev: #44
|
1.4 |
—
|
no change | no change |
P
S
|
587,567 | $25,647,300 | 2023 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
NTRA
NATERA INC
|
Healthcare | 1.03% | 0.80% |
#39
11
Prev: #50
|
0.4 |
—
|
-19,600 | -24.7% |
P
S
|
59,900 | $24,757,269 | 2022 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
EOLS
EVOLUS INC
|
Healthcare | 1.02% | 0.81% |
#40
9
Prev: #49
|
0.9 |
—
|
-71,187 | -2.3% |
P
S
|
3,084,022 | $24,672,176 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
AVTX
AVALO THERAPEUT...
|
Healthcare | 1.02% | 1.11% |
#41
5
Prev: #36
|
0.9 |
—
|
-19,790 | -1.2% |
P
S
|
1,609,392 | $24,671,979 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
KIDS
ORTHOPEDIATRICS...
|
Healthcare | 1.02% | 0.78% |
#42
9
Prev: #51
|
1.4 |
—
|
no change | no change |
P
S
|
1,100,370 | $24,505,240 | 2022 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
RYTM
RHYTHM PHARMACE...
|
Healthcare | 1.01% | 1.57% |
#43
22
Prev: #21
|
0.4 |
—
|
-125,300 | -32.9% |
P
S
|
255,828 | $24,358,663 | 2023 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
DRUG
BRIGHT MINDS BI...
|
Healthcare | 1.00% | 1.26% |
#44
14
Prev: #30
|
1.4 |
—
|
no change | no change |
P
S
|
483,822 | $24,104,012 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MBX
MBX BIOSCIENCES...
|
Healthcare | 0.97% | 1.45% |
#45
19
Prev: #26
|
0.4 |
—
|
-311,929 | -43.9% |
P
S
|
398,951 | $23,386,508 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CRVS
CORVUS PHARMACE...
|
Healthcare | 0.92% | 1.18% |
#46
13
Prev: #33
|
0.9 |
—
|
-194,896 | -9.2% |
P
S
|
1,931,402 | $22,249,751 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
RGEN
REPLIGEN CORP
|
Healthcare | 0.89% | 0.89% |
#47
1
Prev: #46
|
0.4 |
—
|
-65,600 | -37.0% |
P
S
|
111,500 | $21,433,645 | 2023 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
AVLN
AVALYN PHARMACE...
|
Healthcare | 0.88% | 0.98% |
#48
7
Prev: #41
|
0.9 |
—
|
-56,935 | -7.1% |
P
S
|
744,460 | $21,209,665 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
GHRS
GH RESEARCH PLC
|
Healthcare | 0.88% | 0.21% |
#49
31
Prev: #80
|
3.4 |
—
|
695,575 | 335.6% |
P
S
|
902,815 | $21,198,096 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
GH
GUARDANT HEALTH...
|
Healthcare | 0.87% | 0.82% |
#50
2
Prev: #48
|
0.3 |
—
|
-29,940 | -20.3% |
P
S
|
117,910 | $21,030,428 | 2023 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 |
Showing 1-50 of 102 holdings